These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7676548)

  • 21. Levels of activated FXII in survivors of myocardial infarction--association with circulating risk factors and extent of coronary artery disease.
    Kohler HP; Carter AM; Stickland MH; Grant PJ
    Thromb Haemost; 1998 Jan; 79(1):14-8. PubMed ID: 9459314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen in ischaemic heart disease.
    Meade TW
    Eur Heart J; 1995 Mar; 16 Suppl A():31-4; discussion 34-5. PubMed ID: 7796828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
    Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D
    Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma fibrinogen--a major coronary risk factor.
    Stone MC; Thorp JM
    J R Coll Gen Pract; 1985 Dec; 35(281):565-9. PubMed ID: 4093900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis.
    Fatah K; Hamsten A; Blombäck B; Blombäck M
    Thromb Haemost; 1992 Aug; 68(2):130-5. PubMed ID: 1384157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.
    Grandi NC; Breitling LP; Hahmann H; Wüsten B; März W; Rothenbacher D; Brenner H
    Heart; 2011 Aug; 97(15):1215-21. PubMed ID: 21586795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
    Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
    N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen and cardiovascular risk.
    Heinrich J; Assmann G
    J Cardiovasc Risk; 1995 Jun; 2(3):197-205. PubMed ID: 7584794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fibrinogen serum levels in patients with stable coronary artery disease and acute coronary syndrome].
    Gil M; Zarebiński M; Olszewski R; Adamus J
    Pol Merkur Lekarski; 2000 Aug; 9(50):531-2. PubMed ID: 11081317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
    Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
    Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-sensitivity cardiac troponin for risk prediction in patients with and without coronary heart disease.
    Hochholzer W; Valina CM; Stratz C; Amann M; Schlittenhardt D; Büttner HJ; Trenk D; Neumann FJ
    Int J Cardiol; 2014 Sep; 176(2):444-9. PubMed ID: 25127973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between hyperfibrinogenemia and severity of coronary heart disease].
    Liu MY; Hu DY; Yan L; Liu WH; Liu RH
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):820-3. PubMed ID: 15634539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage inflammatory protein-1β and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions.
    Xu F; Lv S; Chen Y; Song X; Jin Z; Yuan F; Zhou Y; Li H
    Cardiology; 2012; 121(1):12-9. PubMed ID: 22378071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased exercise thallium-201 lung uptake: a noninvasive prognostic index in two-vessel coronary artery disease.
    Miller DD; Kaul S; Strauss HW; Newell JB; Okada RD; Boucher CA
    Can J Cardiol; 1988 Sep; 4(6):270-6. PubMed ID: 3263175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma fibrinogen--an independent risk factor for ischaemic heart disease.
    Jose J; Selvakumar D; Selvakumar R; Kanagasapabathy AS; Jeyaseelan L
    Indian Heart J; 1998; 50(1):45-8. PubMed ID: 9583286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibrinogen, a cardiovascular risk factor].
    Ferrara E; Cucchi G; Sardeo C
    Minerva Cardioangiol; 1989 Nov; 37(11):473-5. PubMed ID: 2622536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.